RVL Pharmaceuticals plc (RVLP) Reports In-Line Q1 EPS

RVL Pharmaceuticals plc (NASDAQ: RVLP) reported Q1 EPS of ($0.12), in-line with the analyst estimate of ($0.12). Revenue for the quarter came in at $8.8 million versus the consensus estimate of $13.79 million.

For earnings history and earnings-related data on RVL Pharmaceuticals plc (RVLP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c